INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
研究 HSP90 在影响 BRCA1 突变后果中的作用
基本信息
- 批准号:10370315
- 负责人:
- 金额:$ 7.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesBasic ScienceBenignBindingBiological AssayBreast Cancer CellBreast Cancer PatientBuffersCRISPR/Cas technologyCancer BiologyCancer PatientCell LineCell SurvivalCellsChildClinicClinicalCollaborationsCombined Modality TherapyCytogeneticsDNA RepairDiagnosisDoseEngineeringEnvironmentEpigenetic ProcessGeneral PopulationGenesGeneticGenetic PolymorphismGenome StabilityGenome engineeringGenomic InstabilityGenotypeGerm-Line MutationGoalsHSP 90 inhibitionHaploid CellsHeat-Shock Proteins 70Heat-Shock Proteins 90HeterozygoteHumanHuman EngineeringHypersensitivityImpairmentIndividualLeadMalignant NeoplasmsMalignant neoplasm of ovaryMeasuresMediatingMetaphase SpreadMethodologyMolecularMolecular ChaperonesMutagenesisMutagensMutationNon-MalignantPhenotypePopulationPredispositionPropertyProteinsRepair ComplexResearch PersonnelResearch Project GrantsResistanceResolutionRoleScientistSentinelSeveritiesShapesStratificationStressStructureSupporting CellSystemSystems BiologyTaxesTestingThe Cancer Genome AtlasTrainingVariantWorkbasebiological systemscBioPortalcancer cellcareercell typechemotherapycohortdeep sequencingenvironmental stressorfunctional genomicsgene environment interactiongenome sciencesgenotoxicityimprovedinhibitormalignant breast neoplasmmutantnext generationoutcome predictionpatient stratificationpostersprecision medicineprecision oncologyprofessorprotein foldingprotein functionsingle moleculetargeted treatmenttumor
项目摘要
PROJECT SUMMARY
Mutations that inactivate DNA repair factors increase genome instability and cancer susceptibility. Predicting the
phenotypic effects of mutations is confounded by pervasive polymorphisms and elusive environmental modifiers.
This proposal will tackle this problem by utilizing a fundamental epigenetic mechanism that mediates gene-by-
environment interactions in biological systems, protein folding. Proteins must properly fold to function; this is
achieved with help from specialized proteins called protein-folding chaperones. In helping proteins fold and
function, the abundant chaperone HSP90 “buffers” (that is – mitigates) the effects of deleterious mutations.
Environmental stressors tax HSP90 availability within cells thus revealing cryptic phenotypes in a mutant-specific
way. However, the selectivity of HSP90 for cancer mutations remains poorly defined. Addressing this question
will enable preemptive identification of environmentally sensitive genotypes in the population as well as
stratification of cancer patients who would benefit from the use of HSP90 inhibitors. Indeed, HSP90 mediates
resistance in breast cancer cells by buffering a Breast Cancer Associated 1 (BRCA1) protein folding mutant.
Targeted inhibition of HSP90 restores cancer cell sensitivity to genotoxic agents and induces genome instability.
I hypothesize that HSP90 buffers a broad range of mutations in BRCA1, and in doing so renders the induction
of genome instability conditional upon environmental stressors that impair HSP90 function. I will test this
hypothesis by using a powerful approach based on next-generation functional genomics and classical
cytogenetics methodologies to: 1) evaluate chaperone binding as a classifier of BRCA1 missense mutant
severity in cancer patients, 2) determine the HSP90-buffered landscape of BRCA1 mutations, 3) determine how
HSP90 influences the conditional haploinsufficiency of BRCA1 heterozygotes. Each aim will utilize highly specific
HSP90 inhibitors administered at non-toxic doses to specifically target HSP90-buffered mutants and not wild-
type variant controls. I will engineer non-malignant and malignant cells to express HSP90-buffered BRCA1
mutants and measure the effects of HSP90 inhibition on genome stability and cell viability. This work will not only
reveal fundamental mechanisms shaping the manifestations of BRCA1 mutations, but will also establish a
practical approach to improve the efficacy of BRCA1 targeted therapies using HSP90 inhibition to exacerbate
the effects of HSP90-buffered genome instability mutations. This proposal will prepare me for a career as an
independent scientist investigating the molecular mechanisms through which cancer mutations perturb the
function of DNA repair complexes at single-molecule resolution. I have established a career committee of experts
who will train me in high-throughput systems biology and functional genomics, genome instability and cancer
biology, genome engineering, and single-molecule approaches. My career goals synergize with MD Anderson’s
commitment to postdoctoral trainees and the supportive network of professors and clinicians dedicated to the
advancement of precision cancer medicines.
项目摘要
破坏DNA修复因子的突变增加了基因组的不稳定性和癌症易感性。预测
突变的表型效应被普遍的多态性和难以捉摸的环境修饰剂所混淆。
这项提案将通过利用一种基本的表观遗传机制来解决这个问题,
生物系统中的环境相互作用,蛋白质折叠。蛋白质必须正确折叠才能发挥功能;这是
这是在一种叫做蛋白质折叠伴侣的特殊蛋白质的帮助下实现的。帮助蛋白质折叠,
功能,丰富的伴侣HSP 90“缓冲”(即减轻)有害突变的影响。
环境应激因素对细胞内HSP 90的利用率征税,从而揭示了在一种特定的细胞内的神秘表型。
路上了然而,HSP 90对癌症突变的选择性仍然不清楚。处理这个问题
将能够抢先识别人口中对环境敏感的基因型,
将受益于使用HSP 90抑制剂的癌症患者分层。事实上,HSP 90介导
通过缓冲乳腺癌相关1(BRCA 1)蛋白折叠突变体在乳腺癌细胞中的耐药性。
HSP 90的靶向抑制恢复癌细胞对遗传毒性剂的敏感性并诱导基因组不稳定性。
我假设HSP 90缓冲了BRCA 1中广泛的突变,这样做使得诱导
基因组的不稳定性取决于环境应激因素,这些因素会损害HSP 90的功能。我来测试一下
通过使用基于下一代功能基因组学和经典的
细胞遗传学方法:1)评估伴侣结合作为BRCA 1错义突变体的分类器
癌症患者的严重程度,2)确定BRCA 1突变的HSP 90缓冲区,3)确定如何
HSP 90影响BRCA 1杂合子的条件性单倍不足每个目标都将利用高度具体的
以非毒性剂量施用的HSP 90抑制剂特异性靶向HSP 90缓冲突变体而非野生型。
类型变量控件。我将设计非恶性和恶性细胞来表达HSP 90缓冲的BRCA 1
突变体,并测量HSP 90抑制对基因组稳定性和细胞活力的影响。这项工作不仅将
揭示形成BRCA 1突变表现的基本机制,但也将建立一个
使用HSP 90抑制剂改善BRCA 1靶向治疗的有效性的实用方法
HSP 90缓冲基因组不稳定性突变的影响。这个建议将为我的职业生涯做好准备,
独立科学家研究癌症突变干扰细胞的分子机制。
DNA修复复合物在单分子分辨率下的功能。我成立了一个职业委员会
他将在高通量系统生物学、功能基因组学、基因组不稳定性和癌症方面培训我
生物学、基因组工程和单分子方法。我的职业目标与MD安德森的
致力于博士后培训人员和教授和临床医生的支持网络,致力于
精准抗癌药物的进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brant Gracia其他文献
Brant Gracia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brant Gracia', 18)}}的其他基金
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
研究 HSP90 在影响 BRCA1 突变后果中的作用
- 批准号:
10231495 - 财政年份:2021
- 资助金额:
$ 7.17万 - 项目类别:
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
研究 HSP90 在影响 BRCA1 突变后果中的作用
- 批准号:
10574592 - 财政年份:2021
- 资助金额:
$ 7.17万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 7.17万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 7.17万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 7.17万 - 项目类别: